Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer

Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer

Purpose /Objectives Materials/Methods: The National Cancer Database (NCDB) was queried (2004–2017) for patients with RCC who did not have surgical resection but received definitive SBRT. Kaplan-Meier analysis with log-rank test was used to evaluate overall survival (OS). Univariable (UVA) and multiv...

Full description

Bibliographic Details
Main Authors: Kevin T. Tran, Neil C. Chevli, Jay A. Messer, Waqar Haque, Andrew M. Farach, Raj Satkunasivam, Jun Zhang, Jorge Darcourt, Simon S. Lo, Shankar Siva, Edward B. Butler, Bin S. Teh
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Renal cancer
SBRT
Stereotactic Body Radiotherapy
Biologically equivalent dose
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630823000174

Internet

http://www.sciencedirect.com/science/article/pii/S2405630823000174

Similar Items